Loading
Neuro-oncologist who leads the EORTC Brain Tumor Group and co-authors the European glioma guidelines.
Michael Weller is Chair of the Department of Neurology at University Hospital Zurich and Chair of the EORTC Brain Tumor Group. A neuro-oncologist, his specialisms are neuro-oncology, glioma and clinical trials. He led the European Association for Neuro-Oncology (EANO) guidelines on the diagnosis and treatment of adult astrocytic and oligodendroglial gliomas, anaplastic gliomas and glioblastoma, and diffuse gliomas of adulthood, published in The Lancet Oncology and Nature Reviews Clinical Oncology. His trials include studies of temozolomide, lomustine and targeted agents in glioblastoma, and he is linked to the EORTC 26981/NCIC CE.3 trial. His publications are listed on PubMed.
| Title | Journal | Year |
|---|---|---|
| European Association for Neuro-Oncology (EANO) guideline on the diagnosis and treatment of adult astrocytic and oligodendroglial gliomas | The Lancet Oncology | 2017 |
| EANO guideline for the diagnosis and treatment of anaplastic gliomas and glioblastoma | The Lancet Oncology | 2014 |
| EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood | Nature Reviews Clinical Oncology | 2020 |
| Stupp 2005: temozolomide added to radiotherapy for newly diagnosed glioblastoma | New England Journal of Medicine | 2005 |
Shares Robot-placed catheters and live imaging for drug infusion into brain tumours, EORTC 26981 / NCIC CE.3 (Stupp trial), Stupp 2005: temozolomide added to radiotherapy for newly diagnosed glioblastoma, EORTC.
Shares EORTC 26981 / NCIC CE.3 (Stupp trial), Stupp 2005: temozolomide added to radiotherapy for newly diagnosed glioblastoma, Glioma & glioblastoma.
Shares EORTC 26981 / NCIC CE.3 (Stupp trial), Stupp 2005: temozolomide added to radiotherapy for newly diagnosed glioblastoma, Glioma & glioblastoma.
Shares Stupp 2005: temozolomide added to radiotherapy for newly diagnosed glioblastoma, EORTC.
Shares Lomustine (CCNU), Glioma & glioblastoma.
Shares Lomustine (CCNU), Temozolomide, Glioma & glioblastoma.
Shares Lomustine (CCNU), EORTC, Glioma & glioblastoma.
Shares EORTC, Temozolomide, Glioma & glioblastoma.